logging in or signing up Structure Activity Relationship of Carbonic Anhydrase Inhibitors natdempk Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 99 Category: Science & Tech.. License: Some Rights Reserved Like it (0) Dislike it (0) Added: May 16, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Structure Activity Relationship of Carbonic Anhydrase Inhibitors using Surface Plasmon Resonance: Structure Activity Relationship of Carbonic Anhydrase Inhibitors using Surface Plasmon Resonance By Nat DempkowskiMaterials: Materials Biacore T100 Biacore CM5 Sensor Chip Human Carbonic Anhydrase I Bovine Carbonic Anhydrase II Binding and Buffer Solutions EA, EDC, NHS, Acetate, PBS, HEPES, NaOH , Sulfamate Carbonic Anhydrase Inhibitors (Sulfonamides) Human Carbonic Anhydrase IIInhibitors: Inhibitors Sulfanilamide Acetazolamide Celecoxib Ammonium Sulfamate Topiramate Sulpiride Hydrochlorothiazide Methazolamide SaccharinProtein Immobilization: Protein Immobilization Procedure Biacore T100 Prime CM5 sensor chip by running NaOH and Sulfamate into the flow cells Using EA, EDC, NHS solutions, immobilize Carbonic Anhydrase on the chip Measure Response Units of Carbonic Anhydrase immobilized on chip CM5 Sensor ChipInhibitor Response Measurement: Inhibitor Response Measurement Procedure Dilute inhibitors in buffer solution Dilute different concentrations of inhibitors from ~500µM to ~1µM Inject solutions into flow cells with immobilized protein from lowest concentration to highest Run buffer injections after high concentrations to clear accumulation of inhibitors Measure response units using Surface P lasmon R esonance and model kinetics of bindingResponse from Inhibitors: Response from Inhibitors Celecoxib Hydrochlorothiazide Methazolamide Sulfanilamide Topiramate AcetazolamideKinetics Data: Kinetics Data Mw (g/mol) Ka (association) Kd (dissociation) KD (affinity) Rmax (RU) Acetazolamide 222.3 5.42E+06 0.05723 1.06E-08 16.82 Celecoxib 381.4 8.13E+04 0.1267 1.56E-06 26.31 Hydrochlorothiazide 297.7 1.16E+04 0.03752 3.25E-06 22.46 Methazolamide 236.3 5.79E+06 0.07977 1.38E-08 19.51 Sulfanilamide 172.2 2.40E+04 0.05141 2.14E-06 14.99 Topiramate 339.4 8.75E+04 0.02324 2.66E-07 13.32 Ammonium Sulfamate 114.1 No Binding Observed Sodium saccharin 205.2 No Binding Observed Sulpiride 341.4 No Binding ObservedAssociation Rates: Association RatesBinding Affinity: Binding AffinityConclusion: Conclusion Binding Affinity is determined largely by the Stiffness/Flatness of Molecule Double bonded nitrogen group increases association rates greatly. Acetazolamide Methazolamide You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Structure Activity Relationship of Carbonic Anhydrase Inhibitors natdempk Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 99 Category: Science & Tech.. License: Some Rights Reserved Like it (0) Dislike it (0) Added: May 16, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Structure Activity Relationship of Carbonic Anhydrase Inhibitors using Surface Plasmon Resonance: Structure Activity Relationship of Carbonic Anhydrase Inhibitors using Surface Plasmon Resonance By Nat DempkowskiMaterials: Materials Biacore T100 Biacore CM5 Sensor Chip Human Carbonic Anhydrase I Bovine Carbonic Anhydrase II Binding and Buffer Solutions EA, EDC, NHS, Acetate, PBS, HEPES, NaOH , Sulfamate Carbonic Anhydrase Inhibitors (Sulfonamides) Human Carbonic Anhydrase IIInhibitors: Inhibitors Sulfanilamide Acetazolamide Celecoxib Ammonium Sulfamate Topiramate Sulpiride Hydrochlorothiazide Methazolamide SaccharinProtein Immobilization: Protein Immobilization Procedure Biacore T100 Prime CM5 sensor chip by running NaOH and Sulfamate into the flow cells Using EA, EDC, NHS solutions, immobilize Carbonic Anhydrase on the chip Measure Response Units of Carbonic Anhydrase immobilized on chip CM5 Sensor ChipInhibitor Response Measurement: Inhibitor Response Measurement Procedure Dilute inhibitors in buffer solution Dilute different concentrations of inhibitors from ~500µM to ~1µM Inject solutions into flow cells with immobilized protein from lowest concentration to highest Run buffer injections after high concentrations to clear accumulation of inhibitors Measure response units using Surface P lasmon R esonance and model kinetics of bindingResponse from Inhibitors: Response from Inhibitors Celecoxib Hydrochlorothiazide Methazolamide Sulfanilamide Topiramate AcetazolamideKinetics Data: Kinetics Data Mw (g/mol) Ka (association) Kd (dissociation) KD (affinity) Rmax (RU) Acetazolamide 222.3 5.42E+06 0.05723 1.06E-08 16.82 Celecoxib 381.4 8.13E+04 0.1267 1.56E-06 26.31 Hydrochlorothiazide 297.7 1.16E+04 0.03752 3.25E-06 22.46 Methazolamide 236.3 5.79E+06 0.07977 1.38E-08 19.51 Sulfanilamide 172.2 2.40E+04 0.05141 2.14E-06 14.99 Topiramate 339.4 8.75E+04 0.02324 2.66E-07 13.32 Ammonium Sulfamate 114.1 No Binding Observed Sodium saccharin 205.2 No Binding Observed Sulpiride 341.4 No Binding ObservedAssociation Rates: Association RatesBinding Affinity: Binding AffinityConclusion: Conclusion Binding Affinity is determined largely by the Stiffness/Flatness of Molecule Double bonded nitrogen group increases association rates greatly. Acetazolamide Methazolamide